An Observational Study of Patients with Chronic Gastrointestinal Disease

Active, not recruitingOBSERVATIONAL
Enrollment

500,000

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 31, 2037

Study Completion Date

December 31, 2037

Conditions
Gastrointestinal Diseases
Interventions
OTHER

Observational

Observational

Trial Locations (1)

27157

Atrium Health/Wake Forest University School of Medicine, Winston-Salem

All Listed Sponsors
lead

Target PharmaSolutions, Inc.

INDUSTRY

NCT05774080 - An Observational Study of Patients with Chronic Gastrointestinal Disease | Biotech Hunter | Biotech Hunter